
### [MONDO:0004949](http://purl.obolibrary.org/obo/MONDO_0004949)
**Label:** neoplasm of mature b-cells

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0009693](http://purl.obolibrary.org/obo/MONDO_0009693) (multiple myeloma), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0005615](http://purl.obolibrary.org/obo/MONDO_0005615) (plasmacytoma), 

**Corr. equiv. classes:** [Orphanet:29073](http://www.orpha.net/ORDO/Orphanet_29073), [Orphanet:86855](http://www.orpha.net/ORDO/Orphanet_86855), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [OMIM:151400](http://purl.obolibrary.org/obo/OMIM_151400), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [OMIM:613024](http://purl.obolibrary.org/obo/OMIM_613024), [OMIM:612558](http://purl.obolibrary.org/obo/OMIM_612558), [OMIM:612557](http://purl.obolibrary.org/obo/OMIM_612557), [OMIM:609630](http://purl.obolibrary.org/obo/OMIM_609630), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [Orphanet:314701](http://www.orpha.net/ORDO/Orphanet_314701), [OMIM:612559](http://purl.obolibrary.org/obo/OMIM_612559), [OMIM:109543](http://purl.obolibrary.org/obo/OMIM_109543), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545), 

**Class expressions from DL-Learner:**

- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 37.47%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system))) 36.75%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 34.30%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 32.05%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 31.73%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 30.60%
- Thing 30.58%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 30.58%
- [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) 26.97%
- [HP:0001881](http://purl.obolibrary.org/obo/HP_0001881) (Abnormality of leukocytes) 26.97%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 26.71%
- [HP:0004332](http://purl.obolibrary.org/obo/HP_0004332) (Abnormality of lymphocytes) 21.52%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 20.37%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 18.97%
- [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 18.28%


